Evidence map›Paper›PMID 28580422›Full record

ArticleScience advances2017

HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in mice.

Naoya Hashikawa, Yuta Utaka, Takumi Ogawa, Ryo Tanoue, Yuna Morita, Sayumi Yamamoto, Satoru Yamaguchi, Masafumi Kayano, Yoshito Zamami, Narumi Hashikawa-Hobara

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Effects of esketamine on depression-like behavior and dendritic spine plasticity in the prefrontal cortex neurons of spared nerve injury-induced depressed mice.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Molecular chaperones in the brain endothelial barrier: neurotoxicity or neuroprotection?FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Naoya HashikawaDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Yuta UtakaDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Takumi OgawaDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Ryo TanoueDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Yuna MoritaDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Sayumi YamamotoDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Satoru YamaguchiDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Masafumi KayanoDepartment of Emergency Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.
Yoshito ZamamiDepartment of Emergency Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, Japan.
Narumi Hashikawa-HobaraDepartment of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama, Japan.
Okayama University of Science · JPOkayama University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heat shock proteins (HSPs) are stress-induced chaperones that are involved in neurological disease. Although increasingly implicated in behavioral disorders, the mechanisms of HSP action, and the relevant functional pathways, are still unclear. We examined whether oral administration of geranylgeranylacetone (GGA), a known HSP inducer, produced an antidepressant effect in a social defeat stress model of depression in mice. We also investigated the possible molecular mechanisms involved, particularly focusing on hippocampal neurogenesis and neurotrophic factor expression. In stressed mice, hippocampal HSP105 expression decreased. However, administration of GGA increased HSP105 expression and improved depression-like behavior, induced hippocampal cell proliferation, and elevated brain-derived neurotrophic factor (BDNF) levels in mouse hippocampus. Co-treatment with GGA and the BDNF receptor inhibitor K252a suppressed the antidepressant effects of GGA. HSP105 knockdown decreased

Indexed as

Behavior, AnimalAnimalsBrain-Derived Neurotrophic FactorCarbazolesCell LineDepressionDiterpenesGene Expression RegulationHippocampusHSP110 Heat-Shock ProteinsIndole AlkaloidsMaleMiceReceptor, trkBStress, PsychologicalBrain-Derived Neurotrophic FactorCarbazolesDiterpenesgeranylgeranylacetoneHsp105 protein, mouseHSP110 Heat-Shock ProteinsIndole AlkaloidsReceptor, trkBstaurosporine aglycone

Identifiers

PMID28580422
PMCPMC5451194
OpenAlexW2616885069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.